Impact of Different Treatment Strategies on the Prognosis of Ovarian Metastatic Colorectal Cancer Patients: a Prospective, Multi-center, Real-world Study
This prospective, multi-center, real-world study is conducted to investigate the impact of different treatment strategies (systemic chemotherapy combined with oophorectomy or with other local treatment or chemotherapy alone) on the prognosis of ovarian metastatic colorectal cancer patients.
• Histologically confirmed colorectal adenocarcinoma;
• Histologically or radiologically diagnosed with ovarian metastasis, whether or not combined with metastases in other organs;
• Women ≥18 years of age;
• Eastern Cooperative Oncology Group performance status score ≤2;
• Available imaging data if the disease is measurable according to RECIST criteria version 1.1; patients are eligible if there is no measurable lesion.
• Complete medical records;
• Informed consent form signed.